Secondary
Aeglea BioTherapeutics, Inc.
We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.
Symbol
AGLE
Final Price
$9.01
Anticipated Date
TBD
Underwriters
Evercore ISI, BMO Capital Markets, Jones Trading
To view the prospectus for Aeglea BioTherapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277